In RAS/RAF wild-type tumors, PFS was numerically longer in the anti-EGFR group compared to the anti-VEGF group, although this difference did not reach statistical significance (37.6 vs. 15.0 months, p = 0.059).
← all excerpts
Long-Term Outcomes of Patients Undergoing Conversion Surgery After Induction Chemotherapy: Turkish Oncology Group Study.
1
0.0590
0.0590